Abstract. Macrophages are key cells in tissue defense in the periphery and, under certain circumstances, infiltrate the central nervous system, where they may play a similar role in the brain, perhaps supporting the function of microglia. Macrophages have been shown to adopt different activation states in response to various stimuli. Specifically, when exposed to inflammatory stimuli such as interferon (IFN)␥, the cells adopt the M1 phenotype, whereas when exposed to anti-inflammatory cytokines such as interleukin (IL)-4 or IL-13, the M2 phenotype is adopted. While M1 macrophages are associated with tissue defense and destruction of invading pathogens, M2 macrophages are involved in tissue repair and in terminating inflammation. It is well known that an inflammatory microenvironment exists in the brain of aged animals and also in the brain of mice that overexpress amyloid-␤ protein precursor (A␤PP) and presenilin 1 (PS1; A␤PP/PS1 mice), a commonly-used model of Alzheimer's disease (AD). Recent studies have revealed that immune cells, including macrophages, infiltrate the brain in both circumstances raising the possibility that these cells adopt the M1 activation state and contribute to the already-existing neuroinflammation. We set out to examine the responses of bone marrow-derived macrophages prepared from wildtype and A␤PP/PS1 mice and demonstrate that cells from A␤PP/PS1 mice, even after several days in culture, respond more profoundly to IFN␥ than those from wildtype mice. We suggest that this propensity to respond to M1-polarizing stimuli, together with the described changes in the brain of A␤PP/PS1 mice, contribute to the development of chronic neuroinflammation.
INTRODUCTION
Macrophages are particularly plastic cells adopting different phenotypes in response to various stimuli. They are broadly divided into the M1 proinflammatory phenotype, induced by stimuli interferon (IFN)␥ and lipopolysaccharide (LPS), and the M2 anti-inflammatory phenotype induced by antiinflammatory cytokines such as interleukin (IL)-4 and IL-13 [1, 2] . M1 macrophages are involved in tissue defense and are characterized by increased expression of inflammatory markers such as tumor necrosis factor * Correspondence to: Prof. Marina A. Lynch (TNF)␣ and nitric oxide synthase (NOS)2, whereas M2 macrophages are responsible for terminating the inflammatory response, initiating tissue repair and reestablishing homeostasis; consequently these cells are identified by markers including arginase 1 (Arg1) and mannose receptor (MRC1).
Microglia are considered to be the macrophage equivalent in the brain and, as such, share many of their properties [3] ; the evidence indicates that microglia react to polarizing stimuli in a manner that resembles the response of macrophages adopting similar M1 and M2 activation states [4, 5] . Microglia, like macrophages, are professional phagocytes, although it has been suggested that their phagocytic capability is less than that of macrophages [6] . Previous reports have suggested that decreased recruitment of mononuclear cells into the central nervous system (CNS) coincides with an increased plaque burden in an animal model of Alzheimer's disease (AD) [7] . Indeed the phagocytic efficiency of macrophages, in addition to their ability to participate in tissue repair, has led to the proposal that these cells may play an important role in neuroprotection [8] particularly in situations of acute insult [9] . For example, it has been reported that macrophages, which are found in the spinal cord following traumatic injury, participate in tissue recovery [10] , though the likelihood that they adopt the M1, rather than the M2, phenotype when they encounter the inflammatory microenvironment has been raised [11] .
The amyloid-␤ protein precursor (A␤PP)/presenilin 1 (A␤PP/PS1) model is one of the most commonlyused mouse models of AD. The presence of amyloid-␤ (A␤) plaques in the brains of A␤PP/PS1 mice has been observed as early as 4 months of age and plaque numbers increase with age [12] . These mice exhibit memory deficits [13, 14] , as well as evidence of enhanced microglial activation [15] . Recent evidence has indicated that blood-brain barrier (BBB) permeability is increased with age and in A␤PP/PS1 mice [16, 17] , and this is accompanied by the presence of IFN␥-producing peripheral immune cells in the brain [17] . Data from this laboratory has demonstrated that the pathology seems to progress with age [22] . An increase in the number of infiltrating macrophages, and evidence of enhanced expression of the inflammatory cytokines IL-1␤, TNF␣, and IFN␥ has also been observed in the brain with age and in A␤PP/PS1 mice [15, 18, 19] . Therefore, when macrophages infiltrate the brain in these models, they encounter a proinflammatory microenvironment which may stimulate the cells to adopt the M1 phenotype. Here, we set out to compare the responses of macrophages prepared from the bone marrow of A␤PP/PS1 mice and wildtype (WT) mice to polarizing stimuli. The data indicate that bone marrow-derived macrophages (BMDMs) from A␤PP/PS1 mice are more responsive to LPS and IFN␥ whereas their response to IL-4 is not genotype-specific.
MATERIALS AND METHODS

Animals
Groups of male and female 15-24 month-old A␤PPswe/PS1dE9 mice, hereafter referred to as A␤PP/PS1 mice, expressing a chimeric mouse/human amyloid precursor protein (Mo/HuAPP695Swe) and a mutant human presenilin 1 (PS1-dE9), were used in this study. A␤PP/PS1 (Jackson Laboratories, Maine, USA) and WT littermate mice were bred in an SPF animal housing facility in the Bioresources Unit, Trinity College Dublin and maintained under veterinary supervision in a controlled environment (12-h lightdark cycle; 22-23 • C). All experimental work was performed under a license granted by the Minister for Health and Children (Ireland) under the Cruelty to Animals Act 1876 and the European Community Directive 86/609/EEC. Groups of WT and A␤PP/PS1 mice were comprised of similar numbers of males and females and an even spread of ages. No differences in responses of BMDMs prepared from male or female mice were observed. Whole blood was collected from WT and A␤PP/PS1 mice by transcardial perfusion, diluted 1 : 1 with sterile 1X phosphate-buffered saline (PBS), overlaid on Lymphoprep TM (2 ml; Axis-Shield, UK) and centrifuged with the brake off (600 × g, 30 min). Serum was collected to the level of the interface and stored at −80 • C for treatment of endothelial cells. Mice were killed by decapitation, and the brain was rapidly removed and placed on ice. The hippocampi were dissected free from each hemisphere, flash-frozen, and stored at −80 • C for later analysis.
Preparation, culture, and treatments of BMDMs
BMDMs were isolated from the marrow of the femurs and tibias of WT and A␤PP/PS1 mice. The legs of the animals were sprayed with 70% EtOH and the skin and muscle tissue removed from the bones. The bones were sprayed with 70% EtOH, transferred to a sterile flow hood and cut at both ends. The marrow was flushed out into a sterile falcon tube in Dulbecco's modified Eagle's medium (DMEM; 500 ml; Invitrogen, UK) supplemented with heat-inactivated fetal bovine serum (FBS; 50 ml; 10%; Gibco, UK) and penicillin-streptomycin (5 ml; 1%; Gibco, UK). The cell suspension was triturated using a sterile Pasteur pipette, filtered through a nylon mesh filter (40 m; BD Biosciences, US) into a sterile tube and centrifuged (400 × g, 5 min). The supernatant was removed and the pellet resuspended in red blood cell lysis buffer (Sigma Aldrich, UK). The suspension was centrifuged (400 × g, 5 min), the supernatant discarded, cells washed using DMEM and centrifuged once more (400 × g, 5 min). The pellet was resuspended in DMEM supplemented with L929 conditioned media (20%). Cells were seeded in sterile cell culture T75 cm 2 flasks. On day 2, non-adherent cells were removed from the flask and media replaced, these cells remained in culture for a further 6 days, with media being replaced on day 4. On day 6, cells were transferred to 6-well plates (0.5 × 10 6 cells per well) and remained in culture for a further 2 days. Cells were incubated in the presence of LPS (100 ng/ml; from Escherichia coli; Enzo Life Sciences, UK), IFN␥ (50 ng/ml; R&D Systems, UK), or IL-4 (200 ng/ml; R&D Systems, UK) for 24 h, supernatants were collected for analysis of cytokines by ELISA and cells were harvested for analysis of markers of macrophage activation by real-time PCR and flow cytometry; the concentrations of LPS, IFN␥, and IL-4 were selected based on the findings of previous studies [20, 21] . The purity of the BMDM culture was assessed by flow cytometric analysis. BMDMs were identified as CD11b + CD45 high cells, and it was found that >98% of the cells in culture were positive for both of these markers. Furthermore, >95% of these CD11b + CD45 high cells were also positive for CD68.
Analysis of blood-brain barrier permeability by magnetic resonance imaging (MRI)
To assess BBB permeability, we evaluated the signal derived from extravasation of the gadolinium-based contrast agent gadopentate dimeglumine (Clissmann, Ireland). Mice were anaesthetized with 4% isoflurane (Isoflo, Abbott Animal Health, UK) in 100% oxygen by placing them in a clear plastic chamber connected to an anesthetic scavenging system, and filling the chamber with the gas mixture; anesthesia was maintained by delivery of a mixture of isoflurane and oxygen (1.5-2% at 1 liter/min of 100% oxygen). Mice were placed in a specially-designed cradle in a small rodent Bruker Biospec system with a 7 Tesla magnet and a 30 cm core (Bruker Biospin, Germany) and the right lateral tail vein was cannulated to permit delivery of gadopentate dimeglumine. Thus, pre-and post-contrast measurements were determined within the same contrast scan without moving the animal. Contrast imaging was carried out using a T1-weighted fast low angle shot (FLASH) sequence (10 repetitions; 1 repetition time: 2 min, 11 s; dimensions = 128 × 128 voxels per slice). Baseline measurements were acquired on repetition 1, prior to injection of the contrast agent, which was injected at the start of repetition 2. Gadolinium-enhanced contrast images were analyzed using Medical Image Processing, Analysis, and Visualization (MIPAV) software. Anatomically-distinct regions of interest viewed in repetition 1 were overlayed with a 2 × 2 voxel square, and the average pre-contrast intensity measured. Values for each data set were normalized to the pre-contrast measurement and expressed relative to the pre-contrast value.
Cell culture
Mouse brain-derived endothelial cells (bEnd3; ATCC, UK) were grown to confluence in T25 cm 2 flasks in DMEM (ATCC, UK) containing 10% FBS and 1% penicillin-streptomycin (Invitrogen, UK). When confluence was achieved, cells were transferred to 6-well plates (0.5 × 10 6 well) and maintained in culture for a further 24 h. Cells were incubated with DMEM containing serum (5%) from WT or A␤PP/PS1 mice for 3 h after which time cells were harvested and fractionation carried out using a Subcellular Protein Fractionation kit for Cultured Cells as per manufacturer's instructions (Pierce, UK).
PAGE and western blotting
Cytosolic and membrane fractions were assessed for protein expression by electrophoresis and western immunoblotting as previously described [22] . Primary antibodies against claudin-5 (1 : 2000; Invitrogen, UK), occludin (1 : 1000; BD Transduction, UK), zona occludens (ZO)-1 (1 : 1000; Invitrogen, UK) and phosphorylated c-Jun terminal kinase (JNK; 1 : 1000; Cell Signaling Technology, USA) were used with horseradish peroxidase-conjugated secondary antibodies (1 : 10,000; Jackson ImmunoResearch, UK). Bands were visualized using Supersignal West Pico Chemiluminescent Substrate (Thermo Scientific, USA) and images were captured using a Fujifilm LAS-3000 (Brennan & Co., Ireland).
Analysis of mRNA expression by real-time PCR
RNA was isolated from BMDMs or from hippocampal tissue using a Nucleospin ® RNAII kit (Macherey-Nagel GmbH, Germany) and reverse transcribed into cDNA using a High-Capacity cDNA Archive kit (Applied Biosystems, UK) as per manufacturer's instructions. Assay IDs for the genes examined were as follows: ␤-actin (4352341E), TNF␣ (Mm00443258 m1), NOS2 (Mm0040502 m1), Nucleotide-binding oligomerization domain-containing protein 2 (NOD2) (Mm00467543 m1), CD40 (Mm00441891 m1), CD86 (Mm01344638 m1), MRC1 (Mm00485148 m1), Arg1 (Mm00475988 m1), interferon ␥-induced protein 10 (IP-10) (Mm00445235 m1), monocyte chemoattractant protein-1 (MCP-1) (Mm00441242 m1), IFN␥R1 (Mm00599890 m1), and IL-4R␣ (Mm01275139 m1). Real-time PCR was performed using an ABI Prism 7300 instrument (Applied Biosystems, UK) with ␤-actin used as the endogenous control. No age-related change in ␤-actin was observed. In all cases, relative gene expression was calculated with reference to untreated BMDMs from WT mice using the CT method with Applied Biosystems RQ software (Applied Biosystems, UK).
Analysis of inflammatory cytokines by ELISA
IFN␥ concentration was measured in hippocampal homogenates (4 mg/ml protein concentration) by ELISA (R&D Systems, DY485) as previously described [22] and TNF␣ and IL-1␤ concentrations were assessed in supernatant samples obtained from BMDMs. Standard curves were prepared using recombinant proteins diluted in the appropriate buffers as recommended by the manufacturers (PBS containing 1% BSA for brain tissue and DMEM for supernatant samples). Briefly, standards or samples (100 l) were added to antibody-coated 96-well plates and incubated for 2 h at room temperature, plates were washed and samples were incubated in detection antibody for 2 h. Plates were washed and incubated in horseradish peroxidase-conjugated streptavidin (1 : 200 in PBS containing 1% BSA) for 20 min at room temperature. Substrate solution (tetramethylbenzidine; Sigma, UK) was added, incubation continued at room temperature in the dark for 30 min and the reaction was stopped using H 2 SO 4 (1 M). Absorbance measurements were read at 450 nm using a microplate reader (Bio Tek Instruments, USA). Protein concentrations were calculated relative to the appropriate standard curve and expressed as pg/mg brain tissue and the lower limits of detection for IFN␥, TNF␣, and IL-1␤ were 31.2, 31.2, and 15.6 pg/ml, respectively. Cytokine concentrations for all samples measured lay within the appropriate detection range, however, in the case of IFN␥, measured values were adjusted to reflect pg of IFN␥ per mg protein.
Flow cytometry
To assess the presence of macrophages in the brain, mice were transcardially perfused with icecold PBS, brain tissue was dissected free and the meninges removed. The cerebellum was removed and discarded, the corpus callosum and white matter were also removed, and the hippocampus was dissected free and stored for later analysis. The remaining tissue was placed in 1X Hank's Balanced Salt Solution (HBSS; Invitrogen, UK), cross-chopped, homogenized and triturated using fire-polished Pasteur pipettes with three decreasing diameters. Cell suspensions were filtered through a cell strainer (70 M) and cells pelleted by centrifugation (200 × g, 10 min). Cells were resuspended in 70% Percoll (9 ml), underlaid with 100% Percoll (5 ml), and overlaid with 57% Percoll (9 ml), 21.5% Percoll (9 ml), and 1X PBS (9 ml). The gradients were centrifuged (1250 × g, 45 min), mononuclear cells were collected from the 57-70% and 21.5-57% interfaces, and flow cytometric analysis was undertaken as previously described [22] . Cells were blocked in FACS buffer containing purified antimouse CD16/CD32 (1 : 100; BD Biosciences, UK) and infiltrating macrophages were identified by staining for PE-Cy7 anti-mouse CD45 (1 : 100, Bioscience, UK) and Alexa Fluor 647 anti-mouse CD11b (1 : 100; BD Biosciences, UK). A forward versus side scatter gating strategy was employed to exclude debris and dead cells which have characteristically low forward and high side scatter signals. Macrophages are presented as the number of CD11b + CD45 high cells within this live cell population, a strategy commonly employed to identify these cells [23] [24] [25] [26] . BMDMs in culture were also identified as CD11b + CD45 high cells and examined for expression of PE anti-mouse CD40 (1 : 100; BD Biosciences, UK) and Alexa Fluor 488 anti-mouse MRC1 (1 : 100, BioLegend, UK) following treatment. To assess phagocytosis, BMDMs were incubated with amyloid-␤ (1-42) HiLyte™ Fluor 488-labeled (0.5 M; Anaspec, USA) for 2 h following treatment with IFN␥ or IL-4, as described above. Media was replaced with trypan blue (0.2 mg/ml; Sigma, UK) and samples were incubated for 2 min to quench extracellular fluorescence. Phagocytic cells were represented as the number of CD11b + CD45 high cells positive in the fluorescein isothiocyanate (FITC) channel. Immunofluorescence was read immediately on a DAKO CyAn-ADP 7 color flow cytometer with Summit software v4.3 for acquisition. BD™ CompBeads (BD Bioscience, UK) were used to optimize fluorescence settings and further flow cytometric analysis was carried out in FlowJo v7.6.5. Unstained cells and fluorescence minus one (FMO) tubes were used to gate the percentage of positive cells in any channel.
Statistical analysis
All data are expressed as mean ± standard error of the mean (SEM). Data were analyzed using a Student's t-test for independent means or 2-way analysis of variance (ANOVA) where indicated followed by a Bonferroni post hoc test. MRI data were analyzed using a repeated measures ANOVA with genotype and repetition as variables. In addition, a Student's t-test was carried out on the data obtained at the last repetition. Analysis was carried out using Prism software (Graphpad, US).
RESULTS
Infiltration of macrophages into the brain of AβPP/PS1 mice is associated with BBB permeability
The findings indicate that there is an increase in macrophage infiltration into the brain of A␤PP/PS1 mice ( * * p < 0.01; Student's t-test; Fig. 1A ). Infiltrating macrophages were identified as CD11b + CD45 high cells, which are distinct from CD11b + CD45 low microglia (Fig. 1B) . The increase in macrophages is associated with an increase in expression of IFN␥R on BMDMs prepared from A␤PP/PS1 mice ( * p < 0.05; Student's t-test; Fig. 1C ) and a genotyperelated increase in IFN␥ concentration in brain tissue ( * p < 0.05; Student's t-test; Fig. 1D ). Peripheral cells are generally excluded from the brain but can infiltrate as a consequence of a chemotactic signal or an increase in BBB permeability. Thus, significant genotype-and time (repetition)-related increases in signal intensity derived from extravasated gadolinium were observed in the motor cortex (p < 0.01 and p < 0.001 for genotype and time respectively; 2-way ANOVA; Fig. 1E ) and entorhinal cortex (p < 0.001 for both genotype and time; Fig. 1E ). Analysis of the mean value obtained at the last repetition revealed a genotype-related increase in BBB permeability (p < 0.01; Fig. 1E , F; Student's t-test). These data support previous findings which indicated that BBB permeability in several areas of the brain, including hippocampus, was associated with infiltrating cells in the brain of A␤PP/PS1 mice [22] . Furthermore, we report a genotype-related increase in hippocampal mRNA expression of two chemokines, MCP-1 and IP-10 ( * p < 0.05; Student's t-test; Fig. 1G, H) , both of which are chemoattractant for macrophages [3] .
Serum from AβPP/PS1 mice alters tight junction (TJ) protein expression in an endothelial cell line
An intact BBB provides an important protective strategy for limiting the entry of cells into the brain. Given the enhanced BBB permeability in A␤PP/PS1 mice, the impact of circulating factors on BBB integrity was assessed by incubation of an endothelial cell line with serum obtained from WT or A␤PP/PS1 mice. The membrane expression of claudin-5 and occludin, two proteins integral to BBB function, were significantly decreased in endothelial cells exposed to serum from A␤PP/PS1, compared with WT, mice ( * * p < 0.01; * * * p < 0.001; Student's t-test; Fig. 2A, B respectively) . The cytosolic expression of ZO-1, a protein involved in stabilization of the TJ, was significantly decreased in endothelial cells exposed to serum from A␤PP/PS1, compared with WT, mice ( * * p < 0.01; Student's t-test; Fig. 2C ). Interestingly, the expression of the phosphorylated form of the stress-activated protein kinase JNK was significantly enhanced in endothelial cells exposed to serum from A␤PP/PS1, compared with WT, mice ( * p < 0.05; Student's t-test; Fig. 2D ). Several studies have linked cytokine secretion, including IL-1␤, to BBB disruption [27] and a number of proinflammatory cytokines were increased in serum from A␤PP/PS1 mice (Table 1) .
BMDMs from AβPP/PS1 mice are more responsive to IFNγ than those from WT mice
As macrophages enter the brain in A␤PP/PS1 mice and encounter an inflammatory environment [15, 17, 28] , including increased IFN␥ concentration as described above, the possibility exists that the infiltrating cells will adopt the M1 inflammatory phenotype. We assessed the responsiveness of BMDMs, prepared from WT and A␤PP/PS1 mice, to polarizing stimuli IFN␥ and IL-4. IFN␥ significantly increased the mRNA expression of some markers of the M1 activation state [3, 29, 30] including TNF␣ and NOS2 in cells from WT mice ( * * * p < 0.001; ANOVA; Fig. 2A , C) and this IFN␥-induced effect was enhanced in cells from A␤PP/PS1 mice ( + p < 0.05; ++ p < 0.01; ANOVA; Fig. 3A, C) . Whereas IFN␥ exerted no significant effect on supernatant concentrations of TNF␣ and IL-1␤ in cells from WT mice, it increased release of both proteins from A␤PP/PS1 BMDMs ( * p < 0.05; ANOVA; Fig. 3B, D) . While IFN␥ increased CD40 mRNA and protein expression on BMDMs ( * * * p < 0.001; ANOVA; Figs. 4A, B), Fig. 1 . Enhanced BBB permeability in A␤PP/PS1 mice is associated with an increase in macrophage infiltration and chemokine expression. The number of CD11b + CD45 high macrophages was increased in the brain of A␤PP/PS1, compared with WT, mice (A; * * p < 0.01; Student's t-test; n = 10-12). Macrophages were identified as CD11b + CD45 high cells, which are distinct from CD11b + CD45 low microglia; representative FACS plots are shown (B). IFN␥R1 mRNA expression was increased in BMDMs prepared from A␤PP/PS1, compared with WT, mice (C; * p < 0.05; Student's t-test; n = 10-12). IFN␥ concentration was significantly greater in the hippocampus of A␤PP/PS1, compared with WT, mice (D; * p < 0.05; Student's t-test; n = 8-10). Gadolinium-enhanced contrast imaging was used to assess BBB permeability in WT and A␤PP/PS1 mice. Gadolinium was injected at the commencement of repetition 2. At the end of repetition 10, mean signal intensity (SI) was significantly greater in the motor (E) and entorhinal (F) cortices of A␤PP/PS1 compared with WT mice ( * * p < 0.01; Student's t-test; n = 4-6). no genotype-related effect of IFN␥ was observed in either case. NOD2 and CD86 expression are also considered to be markers of the M1 phenotype [3, 29, 30] , and we found that expression of both were increased in cells from WT and A␤PP/PS1 mice following IFN␥ stimulation ( * * * p < 0.001; ANOVA; Figs. 4C, D). This effect was significantly enhanced in cells from A␤PP/PS1 mice ( ++ p < 0.01; ANOVA;
Figs. 4C, D). These data suggest that when infiltrating macrophages are exposed to the inflammatory environment that characterizes the brain of A␤PP/PS1 mice, they respond by adopting the M1 phenotype; this response includes an increase in release of TNF␣ and IL-1␤ which potentially exacerbates the pre-existing inflammation.
BMDMs from AβPP/PS1 mice are more responsive to LPS than BMDMs from WT mice
Incubation of cells in the presence of LPS also induced a significant increase in mRNA expression of TNF␣ and NOS2 ( * * * p < 0.001; ANOVA; Table 2 ) and the LPS-induced effect on TNF␣ and NOS2 mRNA was significantly enhanced in cells from A␤PP/PS1 mice ( + p < 0.05; ANOVA; Table 2 ). Mean expression of TLR4 mRNA was significantly greater in BMDMs prepared from A␤PP/PS1 mice (1.43 ± 0.07, SEM) compared with WT mice (1.02 ± 0.07; * * * p < 0.001; Student's t-test for independent means; Table 2 ).
IL-4 exerts a similar effect on BMDMs from AβPP/PS1 and WT mice
Incubation of BMDMs with IL-4 significantly increased mRNA expression of Arg1 and MRC1, archetypal markers of the M2 phenotype ( * * * p < 0.001; ANOVA; Figs. 5A, B) , however the effect of IL-4 was similar on cells from WT and A␤PP/PS1 mice. IL-4 also increased the expression of MRC1 on BMDMs and the effect was similar in cells from WT and A␤PP/PS1 mice ( * * * p < 0.01; ANOVA; Fig. 5C ). No genotype-related change was observed in IL-4R␣ mRNA expression on BMDMs from WT and A␤PP/PS1 mice (Fig. 5D ).
IFNγ decreases, while IL-4 increases, the ability of BMDMs to phagocytose Aβ
To identify a functional phenotype associated with M1 and M2 BMDMs, we compared the ability of 
DISCUSSION
The significant finding in this study was that BMDMs prepared from A␤PP/PS1 mice respond more profoundly to IFN␥ than BMDMs from WT mice and that this was associated with increased mRNA expression of IFN␥R. In contrast, there was no change in the responsiveness of BMDMs to IL-4, and also no change in mRNA expression of IL-4R␣. The importance of this finding lies in the fact that macrophages infiltrate the brain and encounter an environment in which IFN␥ concentration is elevated; this has the potential to stimulate them to adopt the M1 phenotype and enhance the pre-existing neuroinflammation.
It appears that, in young A␤PP/PS1 mice, Ly6C low CX3CR1 high CCR2 -monocytes are attracted to, and eliminate, the punctate A␤ accumulation around blood vessels suggesting that the cells may not need to infiltrate the parenchyma [31] . However, there is significant literature indicating that macrophages infiltrate the brain of mouse models of AD in both GFPbone marrow chimeras [6, 32] and in mice which were not subjected to irradiation [33, 34] . The evidence suggests that macrophages are more efficient phagocytes than resident microglia [6] and, consistently, bone marrow transplantation was associated with decreased A␤ accumulation [35] . 
Genotype-related increases in BBB permeability and chemokines may induce infiltration of macrophages into the brain
Importantly, the data indicate that there was a significant increase in the number of CD11b + CD45 high macrophages in brain tissue prepared from A␤PP/PS1, compared with WT, mice. While there is no definitive marker which unequivocally distinguishes macrophages from microglia, it is agreed that the relative expression of CD45 is a useful indicator, since it is expressed at much lower levels in resident microglia [36] . Recent data from this laboratory have confirmed a genotype-related increase in the infiltration of macrophages, T lymphocytes, and natural killer cells in A␤PP/PS1 mice [22, 33, 34, 37] . Although the mechanism underpinning cell infiltration remains to be clarified, we demonstrate that it is associated with a genotype-related increase in BBB permeability as assessed by extravasation of gadolinium. In other studies from this laboratory [15, 17, 28] , increased microglial activation has been accompanied by an increase in IL-12 concentration which may trigger macrophages to release IFN␥ [38] . The evidence indicates that microglia in these animals have characteristics of the M1 activation state [39] . A compromised BBB is associated with infiltrating cells [16, 26, [39] [40] [41] and the creation of a chemotactic gradient across the BBB further facilitates cell infiltration. Here, increased expression of IP-10 and MCP-1, which are chemotactic for macrophages, is described in tissue from A␤PP/PS1 mice and these changes contribute to the development of such a gradient. Additionally, serum from A␤PP/PS1 mice, in which inflammatory cytokine concentrations were elevated, was shown to negatively impact on TJ protein expression in a mouse endothelial cell line. These data raise the possibility that circulating factors in the blood of A␤PP/PS1 mice may contribute to the loss of integrity of the BBB. During pathological conditions, cytokines can dysregulate the barrier-forming cells resulting in reorganization of junctions, matrix, focal adhesion or release of barrier-modulating factors including matrix metalloproteases [42] . Previous evidence from this laboratory has demonstrated increased BBB disruption in the hippocampus, which is associated with peripheral cell infiltration, neuroinflammatory changes [43] , and genotype-associated increases in the same chemokines identified in this study. It is worth noting that BBB permeability was increased in several areas of the brain of A␤PP/PS1 mice, though this was not observed in the thalamus (Kelly et al., personal communication).
BMDMs from AβPP/PS1 mice are hypersensitive to M1, but not M2, polarizing stimuli
A significant finding is that the response of BMDMs prepared from A␤PP/PS1 mice to IFN␥, an M1 polarizing stimulus, was greater than in cells from WT mice, with evidence of a genotype-related increase in several archetypal markers of this state including TNF␣, NOS2, NOD2, and CD86 mRNA [29] . While IFN␥ induced release of TNF␣ and IL-1␤ from BMDMs prepared from A␤PP/PS1 mice, this was not the case in cells from WT mice. While these data suggest that BMDMs from A␤PP/PS1 mice are more responsive to IFN␥, it must be acknowledged that the concentration of IFN␥ (50 ng/ml) is much greater than that found in the brain (although lower concentrations of IFN␥ have a similar effect). An additional limitation is that the effect of IFN␥ alone is assessed even though genotype-related increased concentrations of several inflammatory cytokines, which could act synergistically with IFN␥, have been reported [34] . Interestingly, we have found that IL-1␤ and TNF␣ act synergistically with IFN␥ in macrophages prepared from rats (Costello et al., personal communication). The modest IFN␥-induced release of TNF␣ described here is consistent with previous findings which demonstrate that IFN␥ does not trigger significant release of TNF␣ [44] , but acts as a priming stimulus, inducing its transcription so as to allow a rapid response to a subsequent stimulus. We suggest that the production of inflammatory cytokines by macrophages that infiltrate the brain of A␤PP/PS1 mice will add to the pre-existing inflammatory milieu and additionally may play a role in presenting antigen to T cells, thus further contributing to the developing neuroinflammation.
M2 activation is triggered by the anti-inflammatory cytokines IL-4, IL-5, and IL-13 and characterized by upregulation of markers such as Arg1 and MRC1 [5] . Predictably, IL-4 increased expression of both markers in BMDMs although there was no difference in its effect on cells from WT and A␤PP/PS1 mice, underscoring the specificity of the genotype-related response to IFN␥. IL-4R␣ mRNA expression was found to be comparable in BMDMs from A␤PP/PS1 and WT mice and this may explain why these cells respond to IL-4 stimulation in a similar manner. While the authors are unaware of any previous work investigating the responses of macrophages from A␤PP/PS1 mice to inflammatory stimuli, recent evidence from this laboratory has shown that macrophages in the A␤PP/PS1 brain exhibit increased expression of CD80 and CD68, both of which are considered markers of activation [33] . The current data using BMDMs replicates published work on microglia from this laboratory [22] , which demonstrated that microglia from A␤PP/PS1 mice exhibit an enhanced response to IFN␥, as evidenced by increased phosphorylation of signal transducers and activators of transcription (STAT)1. Furthermore, it was also found that the response of microglia from WT and A␤PP/PS1 mice to IL-4 was unchanged, reinforcing the present data.
The inflammatory microenvironment in the brain may induce macrophages to adopt the M1 phenotype and contribute to inflammation in AβPP/PS1 mice
These findings have identified that, even after several days in culture, BMDMs prepared from A␤PP/PS1 mice exhibit increased expression of IFN␥R1 mRNA and that these cells respond more profoundly to IFN␥ in a manner that suggests a genotype-related bias toward adopting an M1 phenotype. The importance of this lies in the fact that macrophages infiltrate the brain of A␤PP/PS1 mice and encounter an inflammatory environment that has the ability to drive the cells toward the M1 activation state. It is interesting to speculate that the cells are primed by the increase in circulating cytokines and/or A␤ which has been described in these mice (Table 1 ) and others [45] . In the context of traumatic injury to the spinal cord, it has been suggested that the inflammatory environment suppresses the M2 phenotype [11] , with the predominant M1 phenotype limiting repair. Recent data from our laboratory have demonstrated that macrophages which gain entry to the brain of A␤PP/PS1 mice exhibit enhanced expression of activation markers [33] , while there is no change in the expression of the M2 phenotypic marker, MRC1 [22] . Previous studies have suggested that infiltrating macrophages have an important role in the clearance of A␤ plaques [6, 7] , however our data indicate that IFN␥-treated BMDMs are less capable of phagocytosing FITC-labelled A␤ than those treated with IL-4. This is consistent with earlier observations which report that macrophages stimulated with LPS and IFN␥ exhibit decreased ability to phagocytose A␤, whereas those stimulated with IL-4 and IL-13 are more effective phagocytes [46] and that macrophages prepared from AD patients exhibit a decreased ability to clear A␤ [47] . Interestingly, transplanted cells from bone marrow have been shown to contribute to microglial stimulation in A␤PP/PS1 mice [48] . It seems likely, based on our observations, that macrophages from A␤PP/PS1 mice may adopt an inflammatory phenotype when they infiltrate the brain and consequently, may no longer be effective in clearing the brain of neurotoxic A␤ peptide.
